People connected to the Northstars' girls volleyball program have had family members with Parkinson's disease.

Gain Therapeutics’ lead drug candidate rexaceract, formerly known as GT-02287, is in clinical development for the treatment ...

In the Phase 3 TEMPO program, AbbVie’s Juvmo elicited significant improvements in motor symptoms and prolonged periods with ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO™ (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for the treatment of ...

A small pilot trial, the first to assess time-restricted eating in Huntington disease, shows the safety and tolerability of ...

AbbVie has won U.S. Food and Drug Administration approval of its Juvmo once-daily oral treatment for the progressive neurological disorder Parkinson's disease. AbbVie on Monday said the green light ...

Juvmo was designed to offer a reduction in motor symptoms, while reducing non-motor side effects, through its more selective ...

The actor's ex-wife, Sarah Quinones, told TMZ on Tuesday that Haskins was in an assisted living facility at the end of his life.

Parkinson’s disease has long been defined in the public imagination by its motor hallmarks: the tremor, the rigidity, the ...

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for the treatment of adults with ...

Dennis Haskins privately battled Parkinson's disease for eight years before his death, according to his caretaker. Sarah ...

AbbVie ( ABBV) announced that the U.S. FDA has approved JUVMO (tavapadon) tablets for the treatment of adults with Parkinson's disease, providing a new oral treatment option for a progressive ...